These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27391601)

  • 1. The cost-effectiveness challenge: is it worth it?
    Knapp M
    Alzheimers Res Ther; 2015 Jan; 7(1):10. PubMed ID: 27391601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.
    Livingston G; Barber J; Rapaport P; Knapp M; Griffin M; Romeo R; King D; Livingston D; Lewis-Holmes E; Mummery C; Walker Z; Hoe J; Cooper C
    Health Technol Assess; 2014 Oct; 18(61):1-242. PubMed ID: 25300037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility and cost-benefit analyses: how did we get here and where are we going?
    Moayyedi P; Mason J
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):527-34. PubMed ID: 15167153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intervention to promote self-management, independence and self-efficacy in people with early-stage dementia: the Journeying through Dementia RCT.
    Mountain G; Wright J; Cooper CL; Lee E; Sprange K; Beresford-Dent J; Young T; Walters S; Berry K; Dening T; Loban A; Turton E; Thomas BD; Young EL; Thompson BJ; Crawford B; Craig C; Bowie P; Moniz-Cook E; Foster A
    Health Technol Assess; 2022 May; 26(24):1-152. PubMed ID: 35536231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness ratios: in a league of their own.
    Birch S; Gafni A
    Health Policy; 1994 May; 28(2):133-41. PubMed ID: 10136058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accounting for the missing opportunity costs in incremental cost-outcome analysis.
    Oliver A
    Appl Health Econ Health Policy; 2002; 1(4):191-6. PubMed ID: 14619248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.
    Mulhern B; Rowen D; Brazier J; Smith S; Romeo R; Tait R; Watchurst C; Chua KC; Loftus V; Young T; Lamping D; Knapp M; Howard R; Banerjee S
    Health Technol Assess; 2013 Feb; 17(5):v-xv, 1-140. PubMed ID: 23402232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.
    Livingston G; Kelly L; Lewis-Holmes E; Baio G; Morris S; Patel N; Omar RZ; Katona C; Cooper C
    Health Technol Assess; 2014 Jun; 18(39):1-226, v-vi. PubMed ID: 24947468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QALY-time: experts' view on the use of the quality-adjusted LIFE year in COST-effectiveness analysis in palliative care.
    Wichmann AB; Goltstein LCMJ; Obihara NJ; Berendsen MR; Van Houdenhoven M; Morrison RS; Johnston BM; Engels Y;
    BMC Health Serv Res; 2020 Jul; 20(1):659. PubMed ID: 32678021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT.
    Surr CA; Holloway I; Walwyn RE; Griffiths AW; Meads D; Kelley R; Martin A; McLellan V; Ballard C; Fossey J; Burnley N; Chenoweth L; Creese B; Downs M; Garrod L; Graham EH; Lilley-Kelley A; McDermid J; Millard H; Perfect D; Robinson L; Robinson O; Shoesmith E; Siddiqi N; Stokes G; Wallace D; Farrin AJ
    Health Technol Assess; 2020 Mar; 24(16):1-172. PubMed ID: 32216870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.
    Bambha K; Kim WR
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):519-26. PubMed ID: 15167152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial.
    Meeuwsen EJ; German P; Melis RJ; Adang EM; Golüke-Willemse GA; Krabbe PF; de Leest BJ; van Raak FH; Schölzel-Dorenbos CJ; Visser MC; Wolfs CA; Vliek S; Rikkert MG
    J Nutr Health Aging; 2009 Mar; 13(3):242-8. PubMed ID: 19262961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The methodology of cost-effectiveness analysis: avoiding common pitfalls.
    Elliott SL; Harris AH
    Med J Aust; 1997 Jun; 166(12):636-9. PubMed ID: 9216584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of the Economic Evidence for Home Support Interventions in Dementia.
    Clarkson P; Davies L; Jasper R; Loynes N; Challis D;
    Value Health; 2017 Sep; 20(8):1198-1209. PubMed ID: 28964453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
    Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
    Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informing a cost-effectiveness threshold for Saudi Arabia.
    Al-Jedai AH; Lomas J; Almudaiheem HY; Al-Ruthia YSH; Alghamdi S; Awad N; Alghamdi A; Alowairdhi MA; Alabdulkarim H; Almadi M; Bunyan RF; Ochalek J
    J Med Econ; 2023; 26(1):128-138. PubMed ID: 36576804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the (near) equivalence of cost-effectiveness and cost-benefit analyses.
    Phelps CE; Mushlin AI
    Int J Technol Assess Health Care; 1991; 7(1):12-21. PubMed ID: 1903360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.